tiprankstipranks
Advertisement
Advertisement

GB:PRTC Stock Latest News

PureTech Showcases Phase 3 Deupirfenidone Push to Raise IPF Treatment Bar
Company AnnouncementsPureTech Showcases Phase 3 Deupirfenidone Push to Raise IPF Treatment Bar
7d ago
PureTech’s Founded Entity Seaport Therapeutics Prices Upsized $254.9 Million Nasdaq IPO
PremiumCompany Announcements
PureTech’s Founded Entity Seaport Therapeutics Prices Upsized $254.9 Million Nasdaq IPO
19d ago
PureTech Health Balances Clinical Wins With Cash Demands
PremiumCompany Announcements
PureTech Health Balances Clinical Wins With Cash Demands
21d ago
PureTech Health to delist American depositary shares from Nasdaq
PremiumThe Fly
PureTech Health to delist American depositary shares from Nasdaq
21d ago
PRTC
PureTech Health Sharpens Strategy as Portfolio Advances and Cash Runway Extends to 2028
PremiumCompany Announcements
PureTech Health Sharpens Strategy as Portfolio Advances and Cash Runway Extends to 2028
21d ago
PureTech to Delist Nasdaq ADSs and Focus Trading on London Stock Exchange
PremiumCompany AnnouncementsPureTech to Delist Nasdaq ADSs and Focus Trading on London Stock Exchange
21d ago
PureTech-Founded Seaport Therapeutics Adds Veteran Neuropsychiatry Dealmaker to Board
Premium
Company Announcements
PureTech-Founded Seaport Therapeutics Adds Veteran Neuropsychiatry Dealmaker to Board
23d ago
PureTech Health announces data from Phase 1b trial of LYT-200
Premium
The Fly
PureTech Health announces data from Phase 1b trial of LYT-200
28d ago
PRTC
PureTech Unit Gallop Oncology Reports Strong Early Data for LYT-200 in High-Risk Blood Cancers
PremiumCompany Announcements
PureTech Unit Gallop Oncology Reports Strong Early Data for LYT-200 in High-Risk Blood Cancers
28d ago
PureTech Health Sets Date for 2025 Annual Results and Investor Presentation
PremiumCompany Announcements
PureTech Health Sets Date for 2025 Annual Results and Investor Presentation
1M ago
PureTech’s Founded Entity Seaport Therapeutics Files for U.S. IPO
PremiumCompany Announcements
PureTech’s Founded Entity Seaport Therapeutics Files for U.S. IPO
1M ago
PureTech Health announces publication of Phase 2b ELEVATE IPF trial results
PremiumThe Fly
PureTech Health announces publication of Phase 2b ELEVATE IPF trial results
2M ago
PRTC
PureTech’s Celea Posts Positive Phase 2b IPF Data, Paving Way for Phase 3 Deupirfenidone Trial
PremiumCompany AnnouncementsPureTech’s Celea Posts Positive Phase 2b IPF Data, Paving Way for Phase 3 Deupirfenidone Trial
2M ago
PureTech founded Seaport announces topline results from GlyphAgo trial
Premium
The Fly
PureTech founded Seaport announces topline results from GlyphAgo trial
2M ago
PRTC
PureTech Spinout Seaport Advances GlyphAgo After Strong Phase 1 Anxiety Data
Premium
Company Announcements
PureTech Spinout Seaport Advances GlyphAgo After Strong Phase 1 Anxiety Data
2M ago
PureTech Health Updates Share Capital and Voting Rights for March 2026
PremiumCompany Announcements
PureTech Health Updates Share Capital and Voting Rights for March 2026
2M ago
PureTech-Backed Seaport Validates Oral Prodrug Platform With Human Data on Depression Candidate
PremiumCompany Announcements
PureTech-Backed Seaport Validates Oral Prodrug Platform With Human Data on Depression Candidate
2M ago
PureTech Health Issues Shares to President as RSUs Vest Under Performance Plan
PremiumCompany Announcements
PureTech Health Issues Shares to President as RSUs Vest Under Performance Plan
2M ago
PureTech updates total voting rights and share capital for February 2026
PremiumCompany Announcements
PureTech updates total voting rights and share capital for February 2026
3M ago
PureTech Health to Highlight Strategy at Leerink Global Healthcare Conference
PremiumCompany AnnouncementsPureTech Health to Highlight Strategy at Leerink Global Healthcare Conference
3M ago
PureTech Health announces orphan drug designation for Deupirfenidone in IPF
Premium
The Fly
PureTech Health announces orphan drug designation for Deupirfenidone in IPF
3M ago
PRTC
PureTech’s Deupirfenidone Wins U.S. and EU Orphan Status for Idiopathic Pulmonary Fibrosis
Premium
Company Announcements
PureTech’s Deupirfenidone Wins U.S. and EU Orphan Status for Idiopathic Pulmonary Fibrosis
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >